Search

Your search keyword '"Creech C"' showing total 621 results

Search Constraints

Start Over You searched for: Author "Creech C" Remove constraint Author: "Creech C"
621 results on '"Creech C"'

Search Results

1. Overview of U.S. COVID-19 vaccine safety surveillance systems

2. Isolation of human antibodies against influenza B neuraminidase and mechanisms of protection at the airway interface

3. Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials

4. Remdesivir for the Treatment of Covid-19 — Final Report

5. Context Matters: Social Psychological Factors That Underlie Academic Performance across Seven Institutions

10. Contributors

15. A Placebo-Controlled Trial of Antibiotics for Smaller Skin Abscesses

17. Metabolomic Signatures Differentiate Immune Responses in Avian Influenza Vaccine Recipients.

18. Clindamycin versus Trimethoprim–Sulfamethoxazole for Uncomplicated Skin Infections

22. Clinical Practice Guideline by the Pediatric Infectious Diseases Society (PIDS) and the Infectious Diseases Society of America (IDSA): 2023 Guideline on Diagnosis and Management of Acute Bacterial Arthritis in Pediatrics

24. Safety, tolerability, and immunogenicity of a 4-antigen Staphylococcus aureus vaccine (SA4Ag): Results from a first-in-human randomised, placebo-controlled phase 1/2 study

25. Safety, tolerability, and immunogenicity of a single dose 4-antigen or 3-antigen Staphylococcus aureus vaccine in healthy older adults: Results of a randomised trial

26. Safety and Immunogenicity of a Delayed Heterologous Avian Influenza A(H7N9) Vaccine Boost Following Different Priming Regimens: A Randomized Clinical Trial.

27. Clinical Practice Guideline by the Pediatric Infectious Diseases Society (PIDS) and the Infectious Diseases Society of America (IDSA): 2023 Guideline on Diagnosis and Management of Acute Bacterial Arthritis in Pediatrics.

28. Population pharmacokinetics and target attainment analyses to identify a rational empirical dosing strategy for cefepime in critically ill patients

29. Development of a Kinetic ELISA and Reactive B Cell Frequency Assay to Detect Respiratory Syncytial Virus Pre-Fusion F Protein-Specific Immune Responses in Infants

37. Contributors

39. Priorities and Progress in Gram-positive Bacterial Infection Research by the Antibacterial Resistance Leadership Group: A Narrative Review.

40. Surveillance for multisystem inflammatory syndrome in U.S. children aged 5-11 years who received Pfizer-BioNTech COVID-19 vaccine, November 2021−March 2022

41. Evaluation of Empirical Dosing Regimens for Meropenem in Intensive Care Unit Patients Using Population Pharmacokinetic Modeling and Target Attainment Analysis

42. Using Administrative Billing Codes to Identify Acute Musculoskeletal Infections in Children

43. Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naïve subjects

47. Registration of ‘NW13493’ hard white winter wheat

48. 597. Are We Dosing Correctly? Population Pharmacokinetic Modeling of Cefepime, Piperacillin-Tazobactam, and Meropenem in Individuals with Cystic Fibrosis

49. Registration of LCS ‘Valiant’ hard red winter wheat

50. Evaluation of mRNA-1273 Vaccine in Children 6 Months to 5 Years of Age

Catalog

Books, media, physical & digital resources